HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Davorka Tomic Selected Research

Davorka Tomic Research Topics

Disease

18Multiple Sclerosis
02/2022 - 02/2014
9Relapsing-Remitting Multiple Sclerosis
12/2021 - 11/2014
3Chronic Progressive Multiple Sclerosis
01/2022 - 01/2021
2Atrophy
01/2022 - 06/2016
2Disease Progression
01/2022 - 11/2014
2Inflammation (Inflammations)
02/2017 - 01/2016
1Progressive Multifocal Leukoencephalopathy
02/2022
1Acute Disease
01/2022
1Optic Neuritis (Retrobulbar Neuritis)
01/2020
1Ganglion Cysts (Ganglion)
01/2020
1Bradycardia
02/2014
1Parkinson Disease (Parkinson's Disease)
03/2010

Drug/Important Bio-Agent (IBA)

16Fingolimod Hydrochloride (FTY720)FDA Link
02/2022 - 02/2014
4Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2019
4GadoliniumIBA
01/2022 - 11/2014
4siponimodIBA
01/2022 - 02/2017
3InterferonsIBA
01/2020 - 05/2016
2Natalizumab (Tysabri)FDA Link
02/2022 - 07/2015
2teriflunomideIBA
01/2020 - 11/2014
1ofatumumabFDA Link
01/2020
1Retinaldehyde (Retinal)IBA
01/2020
1Dimethyl FumarateIBA
11/2014
1Adenosine A2 Receptor AntagonistsIBA
03/2010

Therapy/Procedure

8Therapeutics
02/2022 - 11/2014
1Injections
01/2020